Watch for Dovato, a New Two-Med Combo for HIV

Dovato (doh-VAH-toh) will be a new complete HIV regimen with TWO meds in one pill...for treatment-naive patients.

It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.

Dovato will try to compete with Biktarvy and Triumeq. These THREE-med one-pill combos have an integrase inhibitor...plus TWO nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote